» Authors » Girish Kumar Parida

Girish Kumar Parida

Explore the profile of Girish Kumar Parida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 162
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Singhal T, Agrawal K, Tripathy T, Parida G
Indian J Nucl Med . 2025 Mar; 39(5):393-395. PMID: 40061512
A 48-year-old female, a known case of ulcerative colitis, on routine workup, was incidentally detected to have biochemical hyperthyroidism. Tc pertechnetate thyroid scintigraphy performed for the evaluation of hyperthyroidism revealed...
2.
Rehman A, Singhal T, Singh P, Parida G, Agrawal K, Patro P, et al.
Indian J Nucl Med . 2025 Mar; 39(5):409-410. PMID: 40061506
White adipose tissue (WAT) generally has negligible glucose utilization and thus, shows no or insignificant Fluorine-18 fluoro D-glucose (FDG) uptake. However, corticosteroids can cause altered biodistribution of FDG with increased...
3.
P R, Patro S, Singh P, Parida G, Agrawal K, Mishra S
J Nucl Med Technol . 2025 Jan; 53(1):87-88. PMID: 39814463
Extragonadal choriocarcinoma in men is an extremely rare and highly aggressive malignancy. Inconclusive biopsies due to a high necrotic component often delay diagnosis. Here is such a case, in which...
4.
Singh P, Nayak M, Singhal T, Parida G, Agrawal K, Sahoo B, et al.
Br J Radiol . 2024 Nov; 98(1166):194-200. PMID: 39607776
Objective: Transthoracic CT-guided lung biopsy is associated with risk of pneumothorax, requiring chest tube placement at times. From available literature, we tried to compare the incidence rate of pneumothorax in...
5.
Singhal T, Agrawal K, Mandal S, Parida G
Clin Nucl Med . 2024 Nov; 50(3):e168-e170. PMID: 39499025
68 Ga-Trivehexin is a novel radiotracer binding to "cancer-specific integrin αvβ6." 68 Ga-Trivehexin has high specificity for tumor cells and, thus, has the potential to replace 18 F-FDG PET/CT due...
6.
Bishnoi K, Agrawal K, Patro P, Parida G
Mol Imaging Radionucl Ther . 2024 Oct; 33(3):212-214. PMID: 39373263
The uptake of Tc-99m-uptake of Tc-99m-methylene diphosphonate (MDP) on bone scintigraphy can be seen at sites other than bone in a varying number of benign and malignant conditions. Extraosseous metastatic...
7.
Singh P, Agrawal K, Emerson R, Baranwal A, Patro P, Parida G
Clin Nucl Med . 2024 Oct; 49(11):e619-e621. PMID: 39365084
Peritoneal cancer index is an integral parameter for preoperative assessment of peritoneal disease. Current imaging modalities including 18 F-FDG PET/CT, though superior to CT, underestimate the disease extent, mainly due...
8.
Singh P, Singhal T, Parida G, Kumar P, Sethy M, Das D, et al.
Indian J Nucl Med . 2024 Sep; 39(3):229-231. PMID: 39291066
Thyroid gland metastases from nonthyroidal malignancies are extremely rare. The most common primary malignancies associated with metastasis to thyroid gland include renal cell carcinoma, colorectal carcinoma, lung cancer, and breast...
9.
Singh P, Parida G, Singhal T, Ayyanar P, Behera K, Agrawal K, et al.
J Nucl Med Technol . 2024 Aug; 52(4):364-366. PMID: 39137979
Oncocytic adenomas are rare benign tumors that typically originate in organs such as the kidneys, thyroid, parathyroid, salivary glands, or pituitary gland. Oncocytic adenoma of the adrenal gland is extremely...
10.
Singh P, Agrawal K, Rahman A, Singhal T, Parida G, Gnanasegaran G
World J Radiol . 2024 Aug; 16(7):265-273. PMID: 39086611
Background: Bone is one of the common sites of metastasis from prostate carcinoma. Bone scintigraphy (BS) is one of the most sensitive imaging modalities currently used for bone metastatic work-up....